Search Results - "Satchell CS"

Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.

Authors: Smith, Emma Davies Malvestutto, Carlos Ribaudo, Heather J et al.

Source: Open Forum Infectious Diseases. Apr2025, Vol. 12 Issue 4, p1-11. 11p.

Evaluation of Cardiovascular Risk Profile and Risk Scores of Antiretroviral Therapy-naïve HIV Patients in Eastern India.

Authors: Chaubey, Manaswi Chakravarty, Jaya Gupta, Rishabh et al.

Source: Journal of Global Infectious Diseases. Jul-Sep2024, Vol. 16 Issue 3, p104-110. 7p.

Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells.

Authors: Krüger-Genge, A. Jung, F. Hufert, F. et al.

Source: Clinical Hemorheology & Microcirculation. 2020, Vol. 76 Issue 2, p309-316. 8p.

Influence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV.

Authors: Goedel, A. Müller, S. Schwerdtfeger, C. et al.

Source: Platelets. 2020, Vol. 31 Issue 6, p756-762. 7p.

Étude interventionnelle sur le dolutégravir et les autres antirétroviraux dans l'athérosclérosclérose infra-clinique en milieu hospitalier de Kinshasa.

Alternate Title: Interventional study on Dolutegravir and other antiretrovirals in patients with subclinical atherosclerosis in the Kinshasa Hospital.

Authors: Mashi, Murielle Longokolo Mambimbi, Marcel Mbula Situakibanza, Hippolyte Nani-Tuma et al.

Source: Pan African Medical Journal. May-Aug2023, Vol. 45, p1-16. 16p.

Characteristics, Predictors and Reasons for Regulatory Body Disciplinary Action in Health Care: A Scoping Review.

Authors: Ai-Leng Foong-Reichert Fung, Ariane Carter, Caitlin A. et al.

Source: Journal of Medical Regulation. Oct2021, Vol. 107 Issue 4, p17-31. 15p.

Option Pricing Using a Skew Random Walk Binary Tree.

Authors: Hu, Yuan Lindquist, W. Brent Rachev, Svetlozar T. et al.

Source: Journal of Risk & Financial Management. Apr2024, Vol. 17 Issue 4, p138. 29p.

Short-term in vivo modifications of platelet NADPH oxidase 2 ( NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies.

Authors: Pastori, D Esposito, A Carnevale, R et al.

Source: HIV Medicine. Nov2016, Vol. 17 Issue 10, p774-777. 4p.

Dysregulation of sterol regulatory element-binding protein 2 gene in HIV treatment-experienced individuals.

Authors: Sopeyin, Anuoluwapo Zhou, Lei Li, Min et al.

Source: PLoS ONE. 12/17/2019, Vol. 14 Issue 12, p1-11. 11p.

96-well plate-based aggregometry.

Authors: Chan, Melissa V. Armstrong, Paul C. Warner, Timothy D.

Source: Platelets. Nov2018, Vol. 29 Issue 7, p650-655. 6p.

The immune profile in HIV: A useful signature in future HIV research?

Authors: McGettrick, Padraig M. C. Barco, Elena Alvarez Kaminskiy, Greg et al.

Source: Germs. Jun2018, Vol. 8 Issue 2, p54-57. 4p.

HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide.

Authors: Laurence, Jeffrey Elhadad, Sonia Robison, Tyler et al.

Source: PLoS ONE. 10/31/2017, Vol. 12 Issue 11, p1-16. 16p.

Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.

Authors: Dorjee, Kunchok Baxi, Sanjiv M. Reingold, Arthur L. et al.

Source: BMC Infectious Diseases. 10/27/2017, Vol. 17, p1-12. 12p. 1 Diagram, 6 Charts, 1 Graph.

Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.

Authors: Raffi, F Esser, S Nunnari, G et al.

Source: HIV Medicine. Oct2016 Supplement, Vol. 17, p3-16. 14p.

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia.

Authors: Limsreng, Setha Marcy, Olivier Ly, Sowath et al.

Source: PLoS ONE. 8/31/2016, Vol. 11 Issue 8, p1-13. 13p.

Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors: Nkambule, Bongani B. Mxinwa, Vuyolwethu Mkandla, Zibusiso et al.

Source: BMC Medicine. 11/18/2020, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.

Authors: Sabin, Caroline A. Reiss, Peter Ryom, Lene et al.

Source: BMC Medicine. 3/31/2016, Vol. 14, p1-14. 14p. 4 Charts, 1 Graph.

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.

Authors: Younas, M Psomas, C Reynes, J et al.

Source: HIV Medicine. Feb2016, Vol. 17 Issue 2, p89-105. 17p.

Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls.

Authors: Rönsholt, Frederikke Falkencrone Gerstoft, Jan Ullum, Henrik et al.

Source: BMC Infectious Diseases. 9/24/2015, Vol. 15 Issue 1, p1-9. 9p. 1 Diagram, 2 Graphs.

The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.

Authors: Nkambule, Bongani B. Davison, Glenda Ipp, Hayley

Source: Platelets. May2015, Vol. 26 Issue 3, p250-257. 8p.